NPI: 1023076593 · NEW YORK, NY 10021 · 207WX0107X
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 1,106 | $59K |
| 2019 | 1,663 | $116K |
| 2020 | 1,156 | $208K |
| 2021 | 1,562 | $124K |
| 2022 | 1,803 | $182K |
| 2023 | 1,887 | $136K |
| 2024 | 1,715 | $84K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| J0178 | Aflibercept injection | 769 | 575 | $517K |
| 99214 | 1,844 | 1,799 | $127K | |
| 92250 | 3,059 | 2,955 | $79K | |
| 92134 | 3,058 | 2,960 | $69K | |
| 67028 | 873 | 770 | $41K | |
| J0177 | Inj, aflibercept hd, 1 mg | 52 | 45 | $31K |
| 92014 | 461 | 456 | $27K | |
| 92226 | 727 | 567 | $18K | |
| 92225 | 24 | 14 | $587.92 | |
| G2211 | Complex e/m visit add on | 25 | 25 | $113.66 |